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adherence behaviours: a repeated measure
observational study with HIV seropositive patients
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Abstract
Background: The extent to which patients follow treatments as prescribed is pivotal to treatment success. An
exceptionally high level (> 95%) of HIV medication adherence is required to suppress viral replication and protect
the immune system and a similarly high level (> 80%) of adherence has also been suggested in order to benefit
from prescribed exercise programmes. However, in clinical practice, adherence to both often falls below the
desirable level. This project aims to investigate a wide range of psychological and personality factors that may lead
to adherence/non-adherence to medical treatment and exercise programmes.
Methods: HIV positive patients who are referred to the physiotherapist-led 10-week exercise programme as part of
the standard care are continuously recruited. Data on social cognitive variables (attitude, intention, subjective
norms, self-efficacy, and outcome beliefs) about the goal and specific behaviours, selected personality factors,
perceived quality of life, physical activity, self-reported adherence and physical assessment are collected at baseline,
at the end of the exercise programme and again 3 months later. The project incorporates objective measures of
both exercise (attendance log and improvement in physical measures such as improved fitness level, weight loss,
improved circumferential anthropometric measures) and medication adherence (verified by non-invasive hair
analysis).
Discussion: The novelty of this project comes from two key aspects, complemented with objective information on
exercise and medication adherence. The project assesses beliefs about both the underlying goal such as following
prescribed treatment; and about the specific behaviours such as undertaking the exercise or taking the medication,
using both implicit and explicit assessments of patients’ beliefs and attitudes. We predict that i) the way people
think about the underlying goal of their treatments explains medication and exercise behaviours over and above
the effects of the behaviour-specific thinking and ii) the relationship between adherence to exercise and to medical
treatment is stronger among those with more favourable views about the goal. Results from this study should
identify the key contributing factors to inform subsequent adherence research and afford a more streamlined
assessment matrix. The project also aims to inform patient care practices.
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Background
In the last two decades, owing to the advanced treat-
ment, the long term outlook for HIV-positive patients
has considerably improved and now reached 2/3 of the
normal life-expectancy at age 20 with medication [1].
The escalating costs of HIV treatment underscore the
importance of efficiency in HIV treatment. In addition
to the constantly improving medical treatment regime,
quality of life of HIV-positive patients has received
increased attention. Exercise has been one of the most
popular self-care therapies affording many health bene-
fits and improved well-being, assuming low attrition. A
body of literature has assessed the beneficial effects of
exercise adherence in clinical trials [2-6] but not in
home-based intervention [7]. One plausible explanation
is that clinical trial studies typically use highly motivated
volunteers where adherence is automatically assumed
and met. In real life, adherence to exercise and to med-
ical treatment may fall well below desired levels and hin-
der the effectiveness of such programmes [8].
Exercise is known to be a beneficial auxiliary treatment
in many chronic conditions [9]. Studies investigating ad-
herence to exercise in self-managed settings have fo-
cused on conditions such as heart failure, injury,
rheumatoid arthritis, low back pain or cystic fibrosis
[10-12]. Despite the fact that adherence has been iden-
tified as a major barrier to benefits from exercise-based
treatments [13,14], research among HIV patients are
generally focussed on adherence to medications. The
number of studies reporting the influence of adherence
to exercise among HIV patients is limited. Contrary to
published controlled trials showing the positive effect
of exercise and reports which indicate that 25% of
HIV patients failed to meet daily recommended phys-
ical activity guidelines [15,16], an observational study
suggested that adherence in the clinical setting is ra-
ther low with only half of the referred patients choos-
ing to participate and adhere to the prescribed and
physiotherapist-led exercise programme [17]. Apart
from the missed benefits from exercise, Kyser et al [18]
also found that patients who did not engage in any
aerobic exercise in the last 30 days were more likely to
be non-adherent to medication.
To date, there is a hiatus in studies investigating the
psychosocial determinant of adherence and non-
adherence to physiotherapist-led exercise programmes
in HIV patients, or exploring the relationship and mod-
erating factors between adherence to medical treatment
and prescribed exercise. Furthermore, the relationship
between cognitive factors of adherence to medical treat-
ment regimes and exercise has not been investigated.
Understanding factors that influence volitional behav-
iour has been in the centre of adherence research. Gen-
erally, HIV patients indicate a strong intention to take
their medications as prescribed, but despite this their
observed or self-reported adherence often falls below the
optimal level [19]. In relation to adherence to treatment
regimes among HIV patients, Munro et al [20] reviewed
6 behavioural models applied to promoting adherence in
a limited number of studies but found little evidence for
effectiveness. Studies in the last 5 years appear to be re-
iterating the same conclusion with some finding the
Theory of Planned Behaviour (TPB) [21] instrumental to
enhance adherence [22] whereas others found that only
a small fraction of the variance in intention to adhere to
antiretroviral therapy was explained by the classic TPB
predictor set of attitude, norms and perceived control
[23]. Self-regulatory processes were found to mediate be-
tween intention and adherence [24]. Furthermore, out-
come beliefs about the medication have been found to
be an important factor in determining adherence
[25,26].
Attempts have been made in the past to identify ‘high-
risk’ patients for non-adherence, relying on relatively
stable predictors such as personality or using predictors
that are beyond the patients’ control, such as barriers to
care or medication, complexity of treatment, costs of
medication or required co-payment [27,28]. In fact, in
HIV positive individuals the motivating and deterring
factors for adherence to medical treatment yield a rather
complex picture [29]. As in most self-regulated behav-
iour, personality characteristics influence the self-
regulatory process in HIV adherence. Adherent patients
are characterised by feeling in control, are empowered
and showing proactiveness, as opposed to non-adherent
patients’ perception of being a ‘victim’ of the HIV treat-
ment regime, passiveness and disempowerment [30]. In
clinical practice, low self-efficacy or depression has been
thought to be related to non-adherence to medical treat-
ment and/or rehabilitation [31-35]. Adherent patients
perceived their quality of life to be higher [36] which is
in line with previous findings showing that those with
better well-being are more likely to show interest in fur-
ther improvements [37]. The role of socioeconomic fac-
tors in HIV treatment adherence is ambiguous [38] but
gender [39] and ethnic [18,40,41] differences were
observed.
Scientific justification and theoretical framework
The novelty of this project comes from the theoretical
framework applied and the measurements utilised in
data collection. From the theoretical point of view, the
key aspect of the project is that it is assessing cognitions
about both the underlying goal of following prescribed
treatment and about the specific behaviours such as tak-
ing medication as prescribed and exercise (Figure 1).
From the methodological aspects, the novel elements
are the consideration of both implicit and explicit
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cognitions, along with using objective measures of both
exercise (attendance and clinically meaningful improve-
ment in physical measures, such as improved fitness
level, weight loss, improved circumferential anthropo-
metric measures, improved one repetition maximum
strength measures) and medication adherence (hair
analysis).
The TPB, along with other social cognitive models
[42] and specifically in relation to health actions [43],
assumes that any given behaviour is a functional out-
come of the attitude – intention – behaviour sequence,
which makes the model suitable for understanding and
predicting volitional health-preserving or improving
behaviour. The efficacy of the TPB in relation to health-
related behaviour is dependent on the particular behav-
iour (i.e. adhering to health improvement or engaging in
risky activities), age, time-frame and measurements [44].
Improvement made in order to increase the predictive
power of the TPB model is abundant, including descrip-
tive norms [45], subjective norms [46], self-identity [47],
self-efficacy and locus of control [48], behavioural con-
trol [49], anticipated regret [50,51], desires and emotions
[52], moral norms and anticipated affect [53], social cog-
nition properties [54], prototypes and willingness [55],
conscientiousness [56] and goals and its properties [57].
The variations of the augmented TPB models acknowl-
edges the complexity of factors underlying the ultimate
behavioural choice but nevertheless assume that the be-
haviour is predicted by some combination of social cog-
nitive factors about the behaviour. Whilst each added
variable incrementally increases the predictive power of
the TPB model, it inadvertently introduces some unex-
plained variances with each predictor, thus the price to
be paid for the improvement manifests in complexity.
Meta-analyses have shown that beliefs and attitudes in
the TPB model predict 39% of the behavioural intention
and 27% of the actual behavior, with notably stronger
prediction when behavior was based on self-reports [58].
In order to close the gap between behavioural intention
and actual behaviour, Gollwitzer and Sheeran [59] pro-
posed the addition of implementation intention.
Approaching behaviour from a different angle, the
Control Theory [60] proposes that behavioural choices
are driven by goal pursuits, where desired goals induce
intentions but also serves as reference values against
which the progress of achieving the goals are constantly
monitored and adjusted if necessary. The allowance for
incremental approaches to the desired goals connects
goal theories of behaviour [57] and implementation
intentions [59] via self-regulation by which people con-
trol their feelings and impulses to ensure behavioural
outcomes that are perceived to be desirable. Self-
regulation is a complex process that includes long-term
perspectives in constant monitoring attainments [60] as
Figure 1 Conceptual framework of medication and exercise adherence. Light blue arrows represent the behavioural intention pathway
(TPB). Goal intention models: dark blue arrows denote a pathway where goal intention is an antecedent; dark burgundy arrows show a pathway
where goal intention is a moderator of the behavioural intention.
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well as resisting temptation with the view of pursuing
long term goals [61]. The self-regulatory effect is
thought to rely on a limited energy resource that can be
temporarily depleted, hence exerting effects on other be-
havioural choices made simultaneously or shortly after
[62].
Investigations of the role of self-regulation in long-
term medication adherence [63] revealed that self-
regulation not only accounted for the largest explained
variance in the self-determination theory-based model
but also was the only variable that showed significant
correlation with both self-reported adherence to pre-
scribed medication and pill-count. Self-managed care
based on a self-regulation framework has been shown to
be effective in health-maintenance among people with
chronic health conditions including improvement in
condition, along with better physical and psychosocial
functioning [64]. Other examples for interventions based
on self-regulation theory being successful are related to
reducing risk of coronary heart disease [65], reducing
depression among people suffering from rheumatoid
arthritis [66] and end-stage renal disease [67].
Self-regulation is present in peoples’ daily lives because
discrepancies between expectations and reality in situa-
tions people encounter are inevitable. Successful adap-
tive functioning is based on effective self-regulation by
which people control their impulses, thoughts, feelings
and adjust their behaviour to close or minimize the gap
between their expectations and present experiences. The
information processing models of self-regulation focuses
on the process of constant comparison and feedback be-
tween the current and the desired, informing the neces-
sary adjustment required to the behaviour [68].
However, the way people carry out this task is a reflec-
tion of their individual dispositions. General personality
dimensions and specific self-referent personality traits
are thought to be inseparably intertwined with self-
regulation [69,70]. General personality dimensions such
as conscientiousness [71], impulsiveness vs. constraint
[72] and specific self-referent traits such as self-efficacy
and self-esteem [73] are key components of the self-
regulative process.
Every step of the self-regulative process, which can
manifest in active initiation and maintenance of a goal-
oriented and effortful activity or inhibition of impulsive
behaviour that could jeopardize reaching the desired
state, is influenced by the personality factors. Individual
differences determine people’s dispositional capacity for
self-regulation, as well as affecting the dynamics of the
regulatory processes [69]. Stable individual differences
determine the self-regulatory strategies individuals auto-
matically employ [74]. Personality traits affect how ambi-
tious the goals are; how discrepancies are viewed; and
what self-regulatory strategies are employed. Personality
also influences whether people exhibit flexibility in be-
haviour to achieve the desired goal or increase effort in
following the behavioural path they set themselves on,
initially assuming that the discrepancy between the
desired and current state is to be bridged by trying
harder or one is motivated to find alternative ways to
reach the desired goals. Integrating trait and process
variables self-regulation offers a more comprehensive ac-
count of self-regulation [75].
Demographic factors such as gender and age moderate
the effect of personality factors on goal setting, self-
regulation and behavioural antecedents. Although per-
sonality trait changes occur most dominantly in young
adulthood (20-40 years of age), they gradually change at
a very slow pace over the lifespan: self-control generally
increases with age [76-78], along with conscientiousness
[79], self confidence and emotional stability [78]. Gender
differences are small relative to individual variation
within genders and broadly conform with gender stereo-
types of males being more assertive than females who
perceive themselves higher than males on agreeableness,
warmth and neuroticism while being open to feelings,
rather than ideas [80] but no difference exists in impul-
siveness, locus of control or orderliness [81]. Males pos-
sess slightly higher general self-esteem compared to
females [82]. On the contrary, ethnicity within the same
culture does not seem to exert a significant influence on
behaviour but rather culture is seen as aggregate person-
ality profiles [83] that manifest in typical behaviour of
most, but not all, people in a given country [84]. Al-
though cultural differences in broad personality traits
have been consistently shown in cross-cultural studies
[85], within culture differences in personality traits by
ethnicity were found to be generally negligible [86].
The integration of the relevant goal-intention-
behaviour theories is depicted in Figure 1. It shows a
conceptual map that underpins the current investigation
in adherence to prescribed exercise and treatment re-
gime among HIV positive patients. Light blue arrows
show the behavioural intention model based on TPB.
Arrows coloured in dark blue and dark burgundy lay out
the path for the goal intention model, where explicit and
implicit goal intentions are either an antecedent (Goal
intention ! Behavioural intention ! Adherence, shown
in dark blue) or a moderator (Behavioural intention !
Goal intention ! Adherence, shown in dark burgundy)
of the behavioural intention. In the latter case, we expect
the strength of the path between behavioural intention
and adherence being diminished or weakened by the in-
clusion of goal intention between behavioural intention
and adherence [87].
A person’s ability to follow a long-term interest via
self-regulation plays a vital role in medical treatment,
particularly in conditions that require prolonged health
Jones et al. BMC Public Health 2012, 12:587 Page 4 of 17
http://www.biomedcentral.com/1471-2458/12/587
management (e.g. chronic conditions or HIV). Although
many segments of self-regulation appear to be in the un-
conscious and automatic domain, health improvement
or maintenance requires conscious, effortful and goal-
oriented self-regulatory behaviour. That is not to say
that unconsciously held motivators do not play an im-
portant role in consciously self-regulated behaviour.
Dual process models [88] suggest the existence of a two-
tier system where the higher-order system is responsible
for reflective and planned behaviour whilst the lower-
order system responds to associative cues at the moment
[89].
Automatic processes occur without intention or
awareness whereas controlled processes are based on
intentional effort to either seek information in order to
choose the appropriate action or to inhibit automatic
processes in order to execute the selected action.
Clearly, implicit automatic and explicitly controlled pro-
cesses are qualitatively different entities that independ-
ently contribute to regulating human behaviour [90,91].
Research in implicit social cognition provides ample evi-
dence that thought processes outside the conscious do-
main influence behaviour and that the processes under
conscious control constitute only a small fraction com-
pared to what is present in decisions about behaviour
[92]. The distinction between automatic implicit and
self-controlled explicit processes has been evidenced in
motivation [93], attitudes, stereotypes, self-esteem and
self-concept [94,95] with considerable individual differ-
ences in awareness of and ability to control automatic
processes [92,96] being evidenced. Despite this, most
policy development narrow-mindedly assumes that be-
havioural choices are exclusively under the controlled
processes when devising preventive measures and inter-
ventions to encourage the desirable behaviour [97]. In
order to improve the effectiveness of such measures, so-
cial policies aiming to behavioural change should incorp-
orate assessment of both implicit and explicit processes
[97].
Therefore for the current project it is proposed that
explicit assessment is complemented with implicit asso-
ciations [98] where appropriate. It is known that indivi-
duals may be biased in how they see themselves and this
bias is often not recognised by the individual [99]. Self-
reported, explicit assessments of individual differences
are particularly prone to distortion, which may or may
not be deliberate. A current research stream in psych-
ology focusing on the uncontrolled, unconscious pro-
cesses [95] provides a promising avenue to compliment
the explicit assessments. Based on the widespread defin-
ition of attitude as a relatively stable tendency to evalu-
ate an attitude object with some degree of like or dislike,
implicit attitudes are defined as associative processes
reflecting this tendency [100]. Associative evaluations
are the result of stimulus driven, uncontrolled, uninten-
tional, goal independent or unconscious processes [101]
and as such, they do not require respondents to be
aware of these attitudes and may be free of self-
presentation distortion in some key cognitions such as
conscienciousness [102]. Recent research has shown that
implicit association adds to the predictive power of ex-
plicit attitude measures [103] via one of eight possible
mechanisms [104]. Based on the assumption that impli-
cit associations either predict or moderate the relation-
ship between antecedents and actual behaviour, Implicit
Association Tests (IAT) have been applied to understand
consumer behaviour [105-107], job satisfaction among
nurses caring for drug addicts [108], doping behaviour
[109] academic performance [110], suicide attempts
[111,112], addiction [113], dietary change [114], dental
hygene [115] or HIV-risk sexual behaviour [116], illus-
trating the widespread use of the IAT concept. In the
current project, using the Brief IAT (BIAT) concept
[117], implicit measures include self-efficacy, attitude
and norms. Implicit tests use exactly-matched content
to explicit measures ensuring that both explicit and im-
plicit measures are equally and directly related to the
concept [118,119].
With adherence constructs being the vital outcome
measures, it is crucially important to have reliable infor-
mation on them. Whilst exercise adherence can be easily
measured by using the attendance log but adherence to
drug treatment is less straightforward [120]. As an ob-
jective alternative (at least for research purposes), meas-
uring the levels of anti-HIV drugs in patients' hair has
been proposed [121,122]. Methodologies have already
been developed for detecting the presence of nevirapine
[123], efavirenz, lopinavir and ritonavir [124] and lopinavir/
ritonavir and atazanavir in hair [125] using liquid
chromatography coupled with tandem mass spectrom-
etry (LC-MS/MS). In this project, hair analysis is
planned to test for the presence of the key anti-viral
drugs, including new method development for tenofovir
and abacavir in hair, to verify self-reports on adherence
or non-adherence. As indirect outcome measures, clinic-
ally meaningful improvement [126,127] is expected in
fitness, circumference measures and perceived quality of
life.
Research question
Although a high level of adherence is required to benefit
from prescribed medication and exercise programmes,
in clinical practice adherence occurs on a continuum
and often falls below the desirable level. Therefore, the
primary objective of this project is to investigate psycho-
logical and socio-economical factors that may lead to ad-
herence/non-adherence to medical treatment and
exercise programmes, with the view of identifying the
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key contributing factors to inform patient care practices
and subsequent adherence research. In addition, the pro-
ject explores the extent to which explicit and implicit
cognitions about the underlying goal predict variance in
medication and exercise adherence. Specifically, we pre-
dict that cognitions about the underlying goal explain
variance in medication and exercise behaviours and in
the relationship between adherence to both exercise and
adherence to medical treatment over and above the
effects of the behaviour specific cognitions (Figure 1).
The goal intention is an antecedent or a moderator of
the behavioural intention.
Hypothesis
We hypothesise that the way people think about the
underlying goal of their treatments explains medication
and exercise behaviours over and above the effects of
the behaviour-specific thinking. We also predict that the
relationship between adherence to exercise and to med-
ical treatment is stronger among those with more
favourable views about the goal.
Specifically, based on models predicting health behav-
iour, we expect that
1. explicit and implicit cognitions (e.g. attitude,
subjective norms, etc.) about the behaviour predicts
variance in medication and exercise behaviours;
2. explicit and implicit cognitions (e.g. attitude,
subjective norms, etc.) about the underlying goal
explains (predicts variance in) medication and
exercise behaviours over and above the effects of the
behaviour-specific cognitions;
3. personality characteristics have a modifying effect on
these predictions;
4. there is a positive relationship between adherence to
exercise and adherence to medical treatment; and
5. the relationship between the two is stronger among
those with more favourable cognitions about the
goal.
Method
Setting and participants
The study utilises a repeated measure design with base-
line and two follow-up measures (Figure 2). The
physiotherapist-led exercise intervention takes place be-
tween the baseline and the first follow-up measure. The
second follow up measure serves as a checkpoint
whether exercise (in case adherence was good during
the physiotherapist-led weeks) has been maintained, and
if there is any change in the underlying cognitive pro-
cesses of exercise behaviour and goals. The testing pro-
tocols are very similar at T0, T1 and T2 with a minor
modification which only manifests in phrasing the ques-
tion to reflect the actual situation, pre-post treatment
and follow up. Variables of the testing protocol are listed
in the Additional file 1: Variables and measures.
Data are collected among HIV seropositive patients
attending the outpatient clinic at Guy’s and St Thomas’
Hospital London. Willing participants are assessed
according to the set criteria for inclusion and exclusion.
Inclusion criteria are: diagnosed as HIV positive, phys-
ician assessed and referred to the 10 week gym
programme at Guy’s and St Thomas’ Hospital, age be-
tween 18-55 and able to give informed consent. Default
by inclusion, patients who are medically (physically and/
or mentally) unstable are excluded from the study. Fur-
ther exclusion criteria include those who have attended
the programme within the last 3 months; patient with
insufficient knowledge of English language to perform
the computerised test and/or complete the questionnaire
as assessed by the pre-screening questionnaire and in-
ability to provide hair samples owing to lack of hair or
having hair with aggressive chemical treatment such as
bleaching or perming. Patients with cognitive impair-
ment sufficient to limit ability to perform the compu-
terised test and/or complete the questionnaire are also
excluded. Cognitive status is assessed using the Mini
Mental State Examination (MMSE) test with a cut off
score of 27, following the new guideline [128].
Sample size
The target sample size for recruitment is n = 60 to allow
maximum 35% attrition thus reaching the final sample
size of 40 with completed datasets. The total sample size
consists of two qualitatively different groups: those with
good adherence to exercise programme and those with
poor adherence/drop out/nonattendance. Constant effort
is made to create groups with equal sample sizes.
Sample size calculation was based on the results from
a previous study [17]. Finding statistically significant dif-
ference/relationship with medium effect size (d = 0.3) at
alpha error probability = 0.05, 1 beta error probability =
0.8, two tail analysis for the FAHI Quality of Life (QL)
measure [129] between two groups (independent sam-
ple): n = 44 (combined sample); FAHI QL measure
change in the adherent group (repeated measure): n = 10
(combined sample); and fitness index change in the ad-
herent group (repeated measure): n = 74 (combined sam-
ple). The difference in fitness baseline measure between
adherent and non-adherent patients was very small.
Information on effect sizes for other measures is not
yet available. Using the definition of 'clinically meaning-
ful change', we assume medium effect size. However, a
secondary aim of this study is to establish thresholds for
clinically meaningful change in the key outcome vari-
ables (CD4 count, quality of life, fitness and physical
measures). The present study will provide invaluable in-
formation for future studies regarding the minimum
Jones et al. BMC Public Health 2012, 12:587 Page 6 of 17
http://www.biomedcentral.com/1471-2458/12/587
sample size required to detect clinically significant
change (i.e. + 20 metres in the 6-minute walk test, + 0.5
SD achieved on the FAHI QL questionnaire) and statisti-
cally significant differences.
Recruitment of patients
Eligible participants are continuously recruited by the
physiotherapists at St Thomas' Hospital as they are
identified by their treating physicians as requiring refer-
ral to the 10-week exercise programme as part of their
standard care. In addition, posters are placed in waiting
rooms informing patients about the study and calling
for participants. Finally, the research group are actively
involved in disseminating up to date information about
the project at specialised interest group meetings and
conferences.
Data collection
Each eligible participant is tested three times. The ini-
tial assessment is conducted when the patient is re-
ferred to the exercise programme, has volunteered to
participate, and is eligible for the study (T0). The dur-
ation of the physiotherapist-led exercise programme is
10 weeks, comprising of two, 1-hour sessions per
week. Participants are tested again at the end of the
exercise programme (T1) and again in approximately
10-12 weeks (T2) during which time patients are
assumed to maintain their exercise programme indi-
vidually. All participants are asked to attend the test-
ing sessions, regardless of their level of adherence to
exercise. Participants are compensated for their time
by gift vouchers (value of £75.00 in total) after each
session.
The recruitment is staggered and continuous. The
total timeframe for each patient involved in three testing
sessions is 25 weeks, including post testing and allowing
for delays owing to personal circumstances. Each testing
session will last for approximately 90 minutes with short
breaks between the implicit assessment test blocks or as
required during the completion of the questionnaire and
physical testing. To avoid cognitive fatigue, compu-
terised and paper psychological tests are interspersed be-
tween the elements of the physical tests.
Participants are asked to donate a hair sample at T2.
The hair sample (a diameter of 3 to 4 mms, approxi-
mately 50 hairs), 3-4 cm in length and preferably un-
treated is taken by the attending physiotherapist
cutting near the skin surface using a pair of blunt edge
scissors in appropriate privacy to observe local patient
dignity standards. Depending on hairstyle, if possible,
cuts are taken from different locations of the head to
avoid bald patches. Hair samples are catalogued by the
ID code and stored in a paper envelope tested for the
presence of selected Combination Antiretroviral Ther-
apy (cART) drugs and used to verify adherence to
medical treatment.
Data on individual patients’ medical record, physical
assessment, attendance, psychological tests and hair
sampling are linked via numerical codes. Coding is
undertaken by the physiotherapy researchers. Other
researchers in this project only have access to the coded
(hence anonymous) data set. Data collection and analysis
are completely separated to negate any researcher bias.
Owing to the staggered start-finish of the data collection,
the full dataset is not analysed until the data collection
is complete.
To meet the objectives, this project is designed to
screen a wide range of variables that may contribute
to adherence/non-adherence to medical treatment and
exercise programmes in HIV positive patients with
the view of selecting key variables and establishing
testing protocols to inform a subsequent, large scale
investigation/intervention study. These variables can
be categorised as i) input variables: physical assessment,
psychological assessment, medical information, demo-
graphics; and ii) outcome variables: adherence to treat-
ment, verified by objective information (drug analysis and
attendance log).
Figure 2 Study design diagram. Screening for eligibility (S1), followed by a baseline (T0) and two repeated measures (T1 & T2).
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Pilot testing before finalising the protocol
A male patient from the exercise programme was
involved in reviewing the research protocol, Information
sheet for Participants, and Consent form. He provided
valuable feedback to the research team and amendments
were made throughout to incorporate his comments.
The computerised psychological assessment and self-
report questionnaire was also tested with two volunteers
prior to the data collection. Volunteers were asked to
complete the test in the presence of the physiotherapist
and 'think loud' (i.e. voicing their thought processes).
Data collected during this exercise are excluded from
the final dataset. The main goal of this exercise was to fi-
nalise a testing protocol and the data recording system
with as little ambiguity as possible. Patients whom
assisted the research in these capacities are excluded
from the study.
Variables
Variables for this study were selected from a wide range
of factors known from previous research to influence
adherence. To capture reasons for adherence/non-
adherence beyond verbal declarations, parallel measures
of explicit cognitions with implicit associations is planned.
This approach will allow us to capture cognitions in
situations where participants are i) unaware of what
is being measured or ii) have no conscious access to
the assessed property or iii) have no control over the
measurement outcome. Hair analysis is proposed as
an objective measure of adherence and is used to verify
self-declared adherence.
Implicit associations
Implicit measures of attitude, self-efficacy and intention
are modified from the BIAT [117]. The BIAT consists of
2 trial blocks with 4 categories, 4 exemplars in each.
Contrary to the classic IAT, the BIAT only focuses on 2
of each block’s 4 categories.
For the purpose of this project, the BIAT has been
adapted to adherence to i) exercise and ii) medical
treatment. Adherence is defined as completing all ses-
sions and taking all medication as prescribed. The ad-
herence category (expressed as frequency) is combined
with i) attitude, ii) self-efficacy and iii) behavioural
intention measures (Figure 3). Each of the nine tests
consists of 48 trials in 2 blocks where each block con-
tains 24 trials (8 practice followed by 16 trials). Order
of the blocks within each test is counterbalanced; order
of the target and the order of the tests are randomised
with a short break between every set of 3 IATs, inter-
spersed with physical assessments. Stimuli for the 9
tests are presented in Table 1, each appearing 4 times
in the trials and each appearing twice for the 8 prac-
tice trials. Text in italics indicates the non-focal cat-
egory. The instructions for each test are presented in
Table 2.
The implicit assessment tests are custom made and
programmed under Linux operation system on a laptop
computer (Samsung P500, Intel Core 2 duo, 15.4"
WXGA screen and full size QWERTY keyboard with in-
dividually mounted keys). For security reasons and to
prevent interference, all other software has been
removed from the laptop.
Figure 3 Setup of the Brief Implicit Association Tests. Implicit measures of attitude, self-efficacy and intention toward the goal and two
behaviours.
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Self-reported explicit variables
Explicit measures of attitude contained the exact phrases
used in the IAT as stimuli and rated on a 6-point Likert-
type scale. Statements for the goal attitudes “Following
each of my doctor’s orders is”, medication adherence
“Taking each of my medication is. . .” and “Attending
each of my exercise sessions is. . .” are followed by worth-
while/important/pleasant/nice/unimportant/pointless/
nasty/unpleasant”, giving 3 sets of 8 statements.
Reversed scoring is used for statements containing
‘negative’ words.
Perceived quality of life and overall health in the
screening questionnaire were captured by the answers to
the questions “Would you say your overall quality of life
is. . .” and ‘’Would you say your overall health is. . .” on a
7-point scale ranging from excellent through very good,
good, fair, poor, very poor to unbearable. The single
question self-assessment is based on a previous study
demonstrating that a single question self assessment
regarding one’s health is a reliable indicator of the gen-
eral health [130].
Quality of life was assessed in using the revised Func-
tional Assessment of Human Immunodeficiency Virus
Infection (FAHI) quality of life instrument [129], meas-
uring 5 facets of well-being: physical (13 items), emo-
tional and living with HIV (10 items), functional and
global (13 items), social (8 items) and cognitive function-
ing (6 items).
Validated scales are used to assess conscientiousness
[71], need for cognition [131] and social desirability
[132]. Activity level during the study is self-reported at
each measurement point using the International Physical
Activity Questionnaire [133].
The strength of the combination of motivational forces
influencing a behaviour in question is captured in behav-
ioural intention [21], accounting some 30 percent of the
variances in behaviour [134]. The questions assessing
HIV treatment related intentions are “I will follow each
of my doctor’s orders”, “I will take each of my HIV medi-
cations” and “I will attend each of my exercise sessions /
I will continue with exercise” for goal intention and be-
havioural intentions to be adherent to medication and
exercise regimes, respectively.
Subjective norms are assessed with three questions:
“People who are important to me think that I should..” i)
“follow doctor’s prescription” (goal), ii) “take all my HIV
medications” (adherence to medication) and iii) “attend
for every exercise session / continue with exercise” (adher-
ence to exercise).
Anticipated regret about non-adherence toward medi-
cation and exercise are measured with a single statement
each, rated on a 6-point Likert-type scale: “If I did not
take my prescribed medication, I would feel regretful”
and “If I did not do my prescribed exercises, I would
regret”.
Self efficacy beliefs were measured with three state-
ments rated on a 6-point scale ranging from defin-
itely no to definitely yes. The statements started with
“I am confident that. . .” and followed by “I could take
each of my HIV medications”, “I will be able to man-
age my illness”, and “I can continue with my
exercise”.
Table 1 Stimuli of the adapted Brief Implicit Association Tests (italics denote the non-focal category)
Category Stimuli
Target Goal Following each of my doctor’s orders all, every, entire, total
Not following each of my doctor’s orders none, few, nil, never
Behaviour Attending each of my exercise sessions all, every, entire, total
Not attending each of my exercise sessions none, few, nil, never
Behaviour Taking each of my medications all, every, entire, total
Not taking each of my medications none, few, nil, never
Attribute Attitude (+) Good worthwhile, important, pleasant, nice
(-) Bad pointless, unimportant, unpleasant, nasty
Self-efficacy (+) I can do easy, undemanding, simple, childsplay
(-) I cannot do difficult, demanding, hard, tricky
Intention (+) I intend to planned, expected, wanted, decided
(-) I have no intention unplanned, unexpected, unwanted, undecided
Table 2 Instructions for the modified Brief Implicit Association Tests
Block Instruction for focal key Instruction for non-focal key
1 Press ‘I’ for focal concept 1 OR (+) words Press ‘E’ for anything else [focal concept 2 OR (-) words]
2 Press ‘I’ for focal concept 2 OR (+) words Press ‘E’ for anything else [focal concept 1 OR (-) words]
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Outcome expectations are assessed by six questions
answered on the 5-point scale ranging between not sure
at all and very sure. All questions are preceded by ”How
sure are you that. . .” with medication and exercise being
asked separately. The questions are: “the medication/
exercise will have positive effect on your health”, “the
exercise will make you feel better”, “taking your medication
as prescribed is necessary to manage your illness to expand
your life”, “doing the prescribed exercises will have a long-
term benefit on your health and quality of life”, “if you do
not take your medication exactly as instructed, your illness
will get worse”.
Self-reported adherence to medication was assessed by
a direct question “When was the last time you missed
taking any of your medication?”, with closed answer
options of “within the past week”, “1-2 weeks ago”, “2-
4 weeks ago”, “1-2 months ago”, “more than 2 months
ago” and “never skip medication”.
Reasons for non-adherence, if present, to medication
and exercise were investigated using the ACTG Baseline
Questionnaire [135], with the questionnaire adapted to
adherence to exercise as well. Exercise non-adherence
related reasons were informed by the informal feedback
patients offered to the physiotherapist in the preceding
years prior to this study. Data from the exercise non-
adherence questions will be tested to ascertain if they
form a valid and reliable scale measuring barriers toward
exercise adherence in this special population, and the
scale will be further developed if promising scale proper-
ties are detected in the present sample. The items are
presented in Additional file 2: Reasons for non-
adherence.
The questionnaires used at the three measurement
points are identical apart from minor modification to
phrasing the question in order to reflect the actual situ-
ation. For example, “attending each of my exercise ses-
sion” in T1 are replaced by “continue with my exercise”
in T2 and T3.
Objective measures
The project incorporates objective measures of both ex-
ercise and medication adherence. Exercise adherence is
assessed via attendance logs during the first phase and
self-managed exercise diary during the second phase.
Clinically meaningful improvement in fitness and phys-
ical indicators (i.e. improved fitness level, weight loss,
improved circumferential anthropometric measures) also
serve as a proxy measure for adherence.
Medical adherence is assessed via self-reports corro-
borated by non-invasive hair analysis, using 50 mg of
cut hair samples. Methods are being developed in house
for two HIV drugs, tenofovir and abacavir, as one of the
two presents in all treatment combination for this
sample. The two drugs are quantified using Liquid
Chromatography-Tandem Mass Spectrometry (LC-MS/
MS) following extraction from the hair samples. Owing
to the limitations of the method, hair analysis provides
a crude estimation of adherence and thus is mainly
used to flag up individuals with total absence of the
drug in their hair. Quantified drug results in hair are
compared to the anonymised information on medical
treatment.
Statistical analysis
Treating missing data will be decided upon examining
the pattern (if any) of the missing data. A missing value
may be replaced if necessary, using the average of the
closest 4 neighbours (two below and two above), ranking
participants by the most similar measure as indicated by
the highest correlation between the two measures. Scale
reliability is tested by calculating internal consistency
coefficients (Cronbach alphas or in case of dichotomous
answer mode, Kuder-Richardson formula). Implicit asso-
ciation reliability is calculated using the split-half
method. IAT effect is calculated as the difference in
average response times between the two focal test
blocks, and individually divided by the variance to derive
the D-scores [136,137]. To identify factors influencing
adherence/non-adherence, discriminant function ana-
lysis are used. Using exercise adherence as a continuous
measure (frequency from the attendance log) will also
allow investigating factors that explain the variance in
adherence the most. The relationship between the two
types of adherence is tested using chi-square analysis,
whereas correlation is used to test relationship between
variables measured on a continuous scale. Building upon
strong correlations, the adherent/non-adherent behav-
iour can also be represented by drawing and testing a
structural equation model. Standard statistical analysis
will be performed using SPSS 19.0, SAS 8.0 and R soft-
ware packages. Behavioural models will be tested with
structural equation modelling, using AMOS 6.0.
Achieved statistical power will be estimated with
G*Power 3.0.1 [138].
Project management
Quality control
Owing to the relatively high cognitive demand of the re-
search protocol (series of IATs and a long question-
naire), volunteering participants are assessed for the
cognitive ability and level of English to ensure high qual-
ity data. Recruitment is conducted via the standard care
to create a 'real life' scenario and avoid motivation bias
by recruiting volunteers. The study is designed to inves-
tigate the reasons for adherence and non-adherence in
every day clinical settings, where the research compo-
nent is limited to the psychosocial information which is
Jones et al. BMC Public Health 2012, 12:587 Page 10 of 17
http://www.biomedcentral.com/1471-2458/12/587
equally important from adherent and non-adherent
patients.
Compliance
Participation in the study is entirely voluntary and inde-
pendent of their participation of the prescribed exercise
programme. All participants are asked to attend the
three testing sessions, regardless of their level of adher-
ence to the exercise programme. A £20 shopping vou-
cher (redeemable at a major supermarket) is offered for
attending each of the first two testing sessions followed
by a £35 shopping voucher for attending the third test-
ing session, subject to attending the previous two.
Data storage and confidentiality
Confidentiality is maintained throughout the study. Phy-
siotherapists’ access to personal and medical information
is within the remit of standard care and performs the
coding for the research data. Researchers outside the
Hospital do not have access to personal information and
they will receive the data in anonymous (coded) format.
All participants are allocated a subject number upon
signing consent. All data collected from that point on-
wards are defined by subject number only. Data col-
lected are seen by the physiotherapists and used by the
research team in coded, anonymised form. Clinical infor-
mation is incorporated into the final data set by the phy-
siotherapists. Researchers outside the NHS do not have
access to any identifiable information. All data are
recorded in secure CRFs. Any hard copies and tissue
samples (hair) are stored in a locked fire-proof cabinet.
Personal data beyond that stored in the NHS system are
not collected. Any identifiable and personal data are only
accessed by the standard care providers at the Trust. All
data are protected and confidentiality maintained follow-
ing the NHS Code of Confidentiality [139].
The laptop computer used for the computerised test-
ing is encrypted and password protected. The implicit
assessment tests are custom made and programmed
under Linux operation system with no commercially
available programmes on the laptop. The test results are
recorded by the unique ID codes. Hair samples are con-
sidered as ‘gift’ and kept beyond the scope of this project.
It is envisaged that these anonymous samples may be
complemented with samples from other healthy and un-
healthy populations and used in future projects aiming
to assess health. Hair samples collected from living indi-
viduals are exempt from the Human Tissue Act [140].
Research ethics and approval
Owing to the project design and strict inclusion/
exclusion criteria, the project does not raise ethical con-
cerns. Written consent is obtained by the physiotherapists
after providing full study information. Should a participant
decide to withdraw from the study for any reason,
the participant and all identifiable data or tissue collected
would be removed from the study. Data or hair samples
which are not identifiable to the research team may be
retained.
The project has no foreseeable risk to the participants
and their identity is fully protected. The computerised
and self-reported psychological tests are coded by the
attending physiotherapist and although they present a
cognitive challenge, they are completed in segments be-
tween the elements of the physical tests. The physical
assessment and the 10-week exercise programme are
part of the prescribed treatment. None of the physical
tests are to exhaustion.
Involvement in an exercise programme could poten-
tially cause temporary pain, discomfort and/or incon-
venience but it is part of the standard treatment and the
Trust has a generic risk assessment for gym based exer-
cise. In this study, the risks are minimised by prescribing
clinically indicated simple exercises that are suitable for
each participant and that each participant is observed
doing the exercises under the supervision of a state-
registered physiotherapist. Participants may feel inconve-
nienced at attending pre- and post assessment sessions,
however, their time is compensated with gift vouchers.
The research design does not have any risk related to its
activities.
Testing: computerised testing could have potential
acute cognitive fatigue that may affect executive func-
tion in an immediate follow-up task that would also re-
quire executive control. This has no bearing on normal
functioning and should recover within 10 minutes. Al-
though the questionnaire contains some sensitive ques-
tions as part of the standard quality of life assessment
(e.g. satisfaction with sexual life), they will be analysed
collectively at the group level (adherent/non-adherent)
and will not be discussed face to face with the
participant.
The researchers have no conflict of interest. Psycho-
logical testing is added to the exercise programme
provided within standard care. Researchers will have
no direct benefit or detriment from the outcome
of this study. Knowledge generated in this project will
serve future studies into treatment adherence, which
in turn may lead to increased functional capacity and
physical fitness, better heath and improved quality
of life. Although there is no direct benefit to partici-
pants from the research component (psychological
testing), their contribution will lead to a better under-
standing of motivating factors and barriers to adher-
ence and inform future intervention strategies and
support. The level of service provided (standard care)
is not affected whether patients take part or not in
this study.
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Approval for this study was granted by the NHS Na-
tional Research Ethics Service under reference number
09/H0712/86.
Collaboration
The project is a collaborative work between two aca-
demic institutions, Kingston University and The Univer-
sity of Sheffield; and the Guy’s and St Thomas’ NHS
Foundation Trust London.
Discussion
This multidisciplinary project is novel in many ways.
The project assesses beliefs about both the underlying
goal such as following prescribed treatment; and about
the specific behaviours such as exercising or taking the
medication, using both implicit and explicit assessments
of patients’ beliefs and attitudes. In addition, the project
incorporates objective information on adherence to both
exercise and medication. The outcome of this study will
reveal the extent to which patients adhere to treatment
regimens. Psychological assessment results linked to
known non-adherence will provide indicators to identify
patients who are at risk of non-adherence, and may be
used to inform early prevention and intervention
programmes.
The reality of recruiting relatively large numbers of eli-
gible participants into this trial has been a challenge, to
date lasting 2.5 years. Being solely reliant on appropriate
referrals from the wider team initially led to insufficient
through flow of appropriate potential participants. At
approximately 12 months into the recruitment phase,
measures were taken to increase access to suitable can-
didates though to date, the 40 participants required for
the power calculation have not been recruited.
One of the risk elements to the successful research
project has been identified was a possibility that by sign-
ing up for the study itself has an influence on adher-
ence. In addition to the effort made to obtain data from
non-adherent patients to avoid volunteer bias motiv-
ation, attendance records of the project participants are
continuously monitored and compared to the attendance
logs kept since 2002 at the Hospital. Attendance record
of the current nonparticipating patients serves as an an-
chor to compare attendance of the project participants.
Normal business-as-usual gym group clinical activity
has been maintained throughout the trial period, how-
ever some practical issues ensued which are noteworthy.
Firstly self selected attendance rates for trial participants
has led to inconsistent group sizes and subsequent
unpredictable demand on the therapists involved -
particularly when 2 or 3 participants attend for outcome
measures during the same session. Secondly, in reality
we experienced a large variance in the period of time eli-
gible and consenting participants required to complete
the computer and paper-based tests and this was skewed
towards longer than expected times. This might be re-
flective of our cognitive and language inclusion criteria
being light in this regard and might inadvertently
impacted on drop-out rates and motivation to return for
outcome measurement sessions. Lastly we expected that
recalling participants for T2 would be problematic with
high risk of drop out. We attempted to mitigate it by
offering the highest proportion of remuneration at this
point of the trial pathway. However despite this T2 out-
comes have constituted a number of non-attendees and
we will analyse this impact.
Our experience so far has shown that inclusion criteria
has meant that approximately 1/3 of gym group patients
with a need for supervised exercise, did not fulfil inclu-
sion criteria for participation in the trial. While we
planned the protocol on real-world patients in reality we
could be subjected to typical trial generalisabilty criti-
cism. Published Health Protection Agency (HPA) data
implicates that there is a clear link between ethnic back-
ground, rate and route of HIV transmission. The major-
ity of people living with HIV in South East London are
either white or black African [141] with an increasing
number of people over the age of 50. See Figure 4 for
characteristics of people living with HIV in South East
London during the trial period. To date, the modest co-
hort in this study is reflective of local prevalence data.
Reasons for exclusion to date are language (n = 11),
cognition (n = 10), age (n = 7) and cART naivety (n = 2).
At the time of writing the mean age of group attendee is
46.5 years (range 19-72 years). Sixteen percent (15/94)
of gym group attendees fell above our 55 years cut off
for the trial. On reflection, the attending physiothera-
pists concede that the views of these patients would have
been as valuable as their younger peers. Should our
study progress to stage 2, we do accept that this should
be considered; changing the upper age limit for recruit-
ment would encompass older adults who are living
longer due to high quality cART as well as those con-
tracting the virus later in life.
One potential confounding factor that has emerged
during data collection is potential mismatch between the
medication records on drug treatment regime and what
patients may actually take, which could easily lead to
categorisation as under-adherent (taking less than
expected) or over-adherent (taking more than expected).
Over-adherence has been observed in relation to other
medications and linked to the number of pills [142,143]
and poor cognition [143], although elsewhere over-
adherence was observed at a higher rate among those
who were on the once-daily regime [144]. A fluctuating
pattern of over- and under-adherence to HAART has
been documented [145], suggesting that adherence to
HAART is not a stable characteristics thus any
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observation made based on hair analysis is limited to the
study period. Longitudinal study following both medical
and exercise adherence, along with potential reasons for
over-adherence is warranted. Whilst the medical records
provide detailed and accurate information on the drug
treatment regime prescribed to the patient, including
changes over time, these records may not be the exact
reflection of what patients may take. There is a possibil-
ity of a patient having more than one hospital number in
which case there is a temporary mismatch between the
expected and detected drug in patients’ hair samples. In
summary, caution must be used when making inferences
from the observed discrepancies between medical
records and behaviour, as deviation from the medical
records may not automatically indicate fault on the
patient’s side.
Measures to control for a precise matching between
the time periods investigated and length of hair sample
as possible is advisable. One such measure is using axilla
hair and shaving to skin level at baseline to ensure that
previous treatment regime does not have influence on
the results. This however would be likely to make re-
cruitment more challenging as participants have to
accept having a bald patch at the start of the study if
they normally have axilla hair, and conversely, having ax-
illa hair temporarily for those who routinely remove it.
Nevertheless, it could be a feasible alternative to using
scalp hair, axilla hair being less affected by chemical
treatment. Should the project progress to stage 2, we
envisage to create a shorter testing protocol, retaining
only those variables that significantly differentiate be-
tween adherent and non-adherent patients. Additional
factors may be added if results from this study highlight
the need.
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exercise: Additional file 2.
Trial status
Data collection has started in 2009 and is currently ongoing.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
AP, DN and KH initiated the project. AP and GJ are principle investigators. AP
conceived the study design with assistance from PS, DN, GJ and KH. GJ, KH
and RM facilitate recruitment and collect the data in the clinical setting. TN
developed the software for the computerised psychological tests. AP and PS
are responsible for analysing and interpreting the psychological data. DN is
responsible for overseeing the chemical analyses. All authors have read and
approved the final version of the manuscript.
Funding
The project received funding from The British Academy SG-52075 and Guy’s
& St Thomas’ NHS Foundation Trust Research and Development Salary
Support. Project CLRN number: 7842.
Figure 4 Local HPA prevalence data for South East London, average of 2008-2010 [141]. A: ethnic distribution. B: age and gender
distribution.
Jones et al. BMC Public Health 2012, 12:587 Page 13 of 17
http://www.biomedcentral.com/1471-2458/12/587
Acknowledgement
The authors thank to the patient volunteers at the Thomas’ Hospital NHS
Foundation Trust London who provided valuable feedback on the earlier
versions of the testing protocol thus helped refining the final version.
Author details
1Department of Physiotherapy, Guy’s and St Thomas’ NHS Foundation Trust,
London, UK. 2Department of Biological Physics, Eötvös Loránd University,
Budapest, Hungary. 3School of Life Sciences, Kingston University London,
London, UK. 4Department of Psychology, The University of Sheffield,
Sheffield, UK.
Received: 3 July 2012 Accepted: 16 July 2012
Published: 1 August 2012
References
1. The Antiretroviral Therapy Cohort Collaboration: Life expectancy of
individuals on combination antiretroviral therapy in high-income countries:
a collaborative analysis of 14 cohort studies. Lancet 2008, 372:293–299.
2. Ciccolo JT, Jowers EM, Bartholomew JB: The benefits of exercise training
for quality of life in HIV/AIDS in the post-HAART era. Sport Med 2004,
34:487–499.
3. Hand GA, Phillips KD, Dudgeon WD, William Lyerly G, Larry Durstine J,
Burgess SE: Moderate intensity exercise training reverses functional
aerobic impairment in HIV-infected individuals. AIDS Care 2008, 20:1066–
1074.
4. O’Brien K, Nixon S, Tynan A-M, Glazier RH: Effectiveness of aerobic exercise
in adults living with HIV/AIDS: systemic review. Med Sci Sport Exer 2004,
36:1659–1666.
5. O’Brien K, Tynan A-M, Nixon S, Glazier RH: Effects of progressive resistive
exercise in adults living with HIV/AIDS: systemic review and meta-
analysis of randomized trials. Aids Care 2008, 20:631–653.
6. Fillipas S, Cherry CL, Cicuttini F, Smirneos L, Holland AE: The effects of
exercise training on metabolic and morphological outcomes for people
living with HIV: a systematic review of randomised controlled trials. HIV
Clin Trials 2010, 11:270–82.
7. Baigis J, Korniewicz DM, Chase G, Butz A, Jacobson D, Wu AW: Effectiveness
of a home-based exercise intervention for HIV-infected adults: a
randomized trial. J Assoc Nurses AIDS Care 2002, 13:33–45.
8. Courneya KS: Efficacy, effectiveness, and behavior change trials in
exercise research. Int J Behav Nutr Physical Activity 2010, 7:81.
9. Taylor NF, Dodd KJ, Shields N, Bruder A: Therapeutic exercise in
physiotherapy practice is beneficial: a summary of systematic reviews
2002-2005. Aust J Physiother 2007, 53:7–16.
10. Barbour KA, Miller NH: Adherence to exercise training in heart failure: a
review. Heart Fail Rev 2008, 13:81–89.
11. Myers LB, Horn SA: Adherence to chest physiotherapy in adults with
cystic fibrosis. Health Psychol 2006, 11:915–926.
12. Tijou I, Yardley L, Sedikides C, Bizo L: Understanding adherence to
physiotherapy: findings from an experimental simulation and an
observational clinical study. Psychol Health 2010, 25:231–247.
13. Rhodes RE, Warburton DER, Murray H: Characteristics of physical activity
guidelines and their effect on adherence: a review of randomized trials.
Sports Med 2009, 39:355–375.
14. Williams NH, Hendry M, France B, Lewis R, Wilkinson C: Effectiveness of
exercise-referral schemes to promote physical activity in adults:
systematic review. Br J Gen Pract 2007, 57:979–986.
15. Fillipas S, Oldmeadow LB, Bailey MJ, Cherry CL: A six-month, supervised,
aerobic and resistance exercise program improves self-efficacy in people
with human immunodeficiency virus: a randomised controlled trial. Aust
J Physiotherapy 2006, 52:185–192.
16. Fillipas S, Bowtell-Harris CA, Oldmeadow LB, Cicuttini F, Holland AE, Cherry
CL: Physical activity uptake in patients with HIV: who does how much?
Int J STD AIDS 2008, 19:514–518.
17. Petroczi A, Hawkins K, Jones G, Naughton DP: Exercise programme for HIV
patients and the need for improved adherence: analysis of the
relationship between patient characteristics and attendance. Open AIDS J
2010, 4:148–155.
18. Kyser M, Buchacz K, Bush TJ, Conley LJ, Hammer J, Henry K, Kojic EM, Milam
J, Overton ET, Wood KC, Brooks JT: Factors associated with non-adherence
to antiretroviral therapy in the SUN study. AIDS Care 2011, 23:601–611.
19. Kalichman SC, Rompa D, DiFonzo K, Simpson D, Austin J, Luke W,
Kyomugisha F, Buckles J: HIV treatment adherence in women living with
HIV/AIDS: research based on the Information-Motivation-Behavioral Skills
model of health behavior. J Assoc Nurses AIDS Care 2001, 12:58–67.
20. Munro S, Lewin S, Swart T, Volmink J: A review of health behaviour
theories: how useful are these for developing interventions to promote
long-term medication adherence for TB and HIV/AIDS? BMC Public Health
2007, 7:104.
21. Ajzen I: The Theory of Planned behaviour. Org Behav Human Decision
Processes 1991, 50:179–211.
22. Vissman AT, Hergenrather KC, Rojas G, Langdon SE, Wilkin AM, Rhodes SD:
Applying the theory of planned behaviour to explore HAART adherence
among HOV-positive immigrant Latinos: Elicitation interview results.
Patient Educ Counsel 2011, 85:454–460.
23. Saal W, Kagee A: The applicability of the Theory of Planned Behaviour in
predicting adherence to ART among a South African sample. Health
Psychol 2012, 17:362–370.
24. de Briun, Sheeran P, Kok G, Hiemstra A, Prins JM, Hospers HJ, Breukelen GJP:
Self-regulatory processes mediate the intention-behavior relation for
adherence and exercise behaviours. Health Psychol 2012, doi:10.1037/
a0027425.
25. Horne R: Treatment perceptions and self-regulation. In The self-regulation
of health and illness behaviour. Edited by Cameron LD, Leventhal H. New
York, NY, US: Routledge; 2003:138–153.
26. Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C: The relationship of
disease severity, health beliefs and medication adherence among HIV
patients. Aids Care 2000, 12:387–398.
27. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R: Patient adherence
to HIV medication regimens. A review of published and abstract reports.
Patient Educ Counsel 2002, 46:93–108.
28. Stirrat MJ, Gordon CM: HIV treatment adherence research and
intervention: current advances and future challenges. J HIV AIDS Soc
Services 2007, 1/2:9–22.
29. Sherr L, Lampe F, Norwood S, Leake Date H, Harding R, Johnson M,
Edwards S, Fisher M, Arthur G, Zetler S, Anderson J: Adherence to
antiretroviral treatment in patients with HIV in the UK: a study of
complexity. Aids Care 2008, 20:442–448.
30. Van Dyk AC: Differences between patients who do and do not adhere to
antiretroviral therapy. J Assoc Nurses AIDS Care 2011, 22:269–282.
31. Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, Vella S,
Robbins GK, Protocol Teams of ACTG 384, ACTG 731, A5031s: Factors
influencing medication adherence beliefs and self-efficacy in persons
naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS
Behav 2004, 8:141–150.
32. Amico KR, Harman JJ, Johnson BT: Efficacy of antiretroviral therapy
adherence interventions: a research synthesis of trials, 1996 to 2004. J
Acquir Immune Deficiency Syndr 2006, 41:285–297.
33. Cote JK, Godin G: Efficacy of interventions in improving adherence to
antiretroviral therapy. Int J STD AIDS 2005, 16:335–343.
34. Gonzalez JS, Penedo FJ, Antoni MH, Durán RE, McPherson-Baker S, Ironson
G, Isabel Fernandez M, Klimas NG, Fletcher MA, Schneiderman N: Social
support, positive states of mind, and HIV treatment adherence in men
and women living with HIV/AIDS. Health Psychol 2004, 23:413–418.
35. Kalichman SC: Co-occurrence of treatment nonadherence and continued
HIV transmission risk behaviors: implications for positive prevention
interventions. Psychosom Med 2008, 70:593–597.
36. Carballo E, Cadarso-Suárez C, Carrera I, Fraga J, de la Fuente J, Ocampo A,
Ojea R, Prieto A: Assessing relationships between health-related quality
of life and adherence to antiretroviral therapy. Qual Life Res 2004, 13:587–
599.
37. Clingerman E: Physical activity, social support, and health-related quality
of life among persons with HIV disease. J Community Health Nurs 2004,
21:179–197.
38. Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G: Socioeconomic status
(SES) as a determinant of adherence to treatment in HIV infected
patients: a systematic review of the literature. Retrovirology 2008, 5:13.
39. Ubbiali A, Donati D, Chiorri C, Bregani V, Cattaneo E, Maffei C, Visintini R:
Prediction of adherence to antiretroviral therapy: can patients’ gender
play some role? An Italian pilot study. AIDS Care 2008, 20:571–575.
40. Mugavero MJ, Lin H-Y, Allison JJ, Giordano TP, Willig JH, Raper JL, Wray NP,
Cole SR, Schumacher JE, Davies S, Saag MS: Racial disparities in HIV
Jones et al. BMC Public Health 2012, 12:587 Page 14 of 17
http://www.biomedcentral.com/1471-2458/12/587
virologic failure: do missed visits matter? J Acquir Immune Defic Syndr
2009, 50:100–108.
41. Deschamps AE, Graeve VD, van Wijngaerden E, De Saar V, Vandamme AM,
van Vaerenbergh K, Ceunen H, Bobbaers H, Peetermans WE, de
Vleeschouwer PJ, de Geest S: Prevalence and correlates of nonadherence
to antiretroviral therapy in a population of HIV patients using
Medication Event Monitoring System. AIDS Patient Care STDS 2004,
18:644–657.
42. Armitage CJ, Conner M: Social cognition models and health behaviour: A
structured review. Psychol Health 2000, 15:173–189.
43. Janz NK, Becker MH: The health belief model: A decade later. Health Educ
Quarterly 1984, 11:1–47.
44. McEachan RRC, Conner M, Taylor NJ, Lawton RJ: Prospective prediction of
health-related behaviours with the theory of planned behaviour: a meta
analysis. Health Psychol Rev 2011, 5:97–144.
45. Rivis A, Sheeran P: Descriptive norms as an additional predictor in the
theory of planned behaviour: a meta-analysis. Curr Psychol 2003, 22:218–
233.
46. Manning M: The effects of subjective norms on behaviour in the theory
of planned behaviour: a meta-analysis. Br J Soc Psychol 2009, 48:649–705.
47. Rise J, Sheeran P, Hukkelberg S: The role of self-identity in the theory of
planned behaviour: a meta analysis. J Appl Soc Psychol 2010, 40:1085–
1105.
48. Ajzen I: Perceived behavioral control, self-efficacy, locus of control, and
the theory of planned behavior. J Applied Social Psychol 2002, 31:665–683.
49. Sheeran P, Trafimow D, Armitage CJ: Predicting behaviour from perceived
behavioural control: test of the accuracy assumption of the theory of
planned behaviour. Br J Soc Psychol 2003, 42:393–410.
50. Sheeran P, Orbell S: Augmenting the theory of planned behaviour: roles
for anticipated regret and descriptive norms. J Appl Soc Psychol 1999,
29:2107–2142.
51. Sandberg T, Conner M: Anticipated regret as an additional predictor in
the theory of planned behaviour. Br J Social Psychol 2008, 47:589–606.
52. Perugini M, Bagozzi RP: The role of desires and anticipated emotions in
goal-directed behaviours: broadening and deepening the theory of
planned behaviour. Br J Social Psychol 2001, 40:79–98.
53. Rivis A, Sheeran P, Armitage CJ: Expanding the affective and normative
components of the theory of planned behavior: A meta-analysis of
anticipated affect and moral norms. J Appl Soc Psychol 2009, 39:2985–
3019.
54. Cooke R, Sheeran P: Moderation of cognition-intention and cognition
behaviour relations: a meta-analysis of properties of variables from the
theory of planned behaviour. Br J Social Psychology 2004, 43:159–186.
55. Rivis A, Sheeran P, Armitage CJ: Augmenting the theory of planned
behaviour with the prototype/willingness model; predictive validity of
actor versus abstainer prototypes for adolescents’ health-protective and
health-risk intentions. Br J Health Psychol 2006, 11:483–500.
56. Conner M, Abraham C: Conscientiousness and the theory of planned
behaviour: toward a more complete model of the antecendents of
intentions and behaviour. Pers Soc Psychol Bull 2001, 27:1547–1561.
57. Perugini M, Conner M: Predicting and understanding behavioural
volitions: the interplay between goals and behaviors. Eur J Social Psychol
2000, 30:705–731.
58. Armitage CJ, Conner M: Efficacy of the Theory of Planned Behaviour: a
meta-analytic review. Br J Soc Psychol 2001, 40:471–99.
59. Gollwitzer PM, Sheeran P: Implementation intentions and goal
achievement: a metal analysis of effects and processes. Adv Exp Soc
Psychol 2006, 38:69–120.
60. Carver CS, Scheier MF: Control theory: a useful conceptual framework for
personality – social, clinical and health psychology. Psychol Bull 1982,
92:111–135.
61. Mischel W: From good intentions to willpower. In The psychology of action.
Edited by Gollwitzer P, Bargh J. New York: Guilford; 1996:197–218.
62. Baumeister RF, Vohs KD, Tice DM: The strength model of self-control. Curr
Dir Psychol Sci 2007, 16:351–355.
63. Williams GC, Rodin GC, Ryan RM, Grolnick WS, Deci EL: Autonomous
regulation and long-term medication adherence in adult outpatients. J
Health Psychol 1998, 17:269–276.
64. Clark NM: Management of chronic disease by patients. Annu Rev Public
Health 2003, 24:289–313.
65. Kubzansky LD, Park N, Peterson C, Vokonas P, Sparrow D: Healthy
psychological functioning and incident coronary heart disease: the
importance of self-regulation. Arch Gen Psychiatry 2011, 68:400–408.
66. Knittle K, Maes S, de Gucht V: Psychological interventions for rheumatoid
arthritis: examining the role of self-regulation with a systematic review
and meta-analysis of randomized controlled trials. Arthritis Care Res 2010,
62:1460–1472.
67. Jansen DL, Heijmans M, Rijken M, Kaptein AA: The development of and
first experiences with a behavioural self-regulation intervention for end-
stage renal disease patients and their partners. Health Psychol 2011,
16:274–283.
68. Higgins ET: Self-discrepancy: A theory relating self and affect. Psychol Rev
1987, 94:319–340.
69. McCrae RR, Löckenhoff CE: Self-regulation and the Five-Factor Model of
personality traits. In Handbook of personality and self-regulation. Edited by
Hoyle RH. Oxford, UK: Wiley-Blackwell; 2010.
70. Matthews G, Schwean VL, Campbell SE, Saklofske DH, Mohamed AAR:
Personality, self-regulation, and adaptation: A cognitive-social
framework. In Handbook of self-regulation. 2nd edition. Edited by Boekaerts
M, Pintrich PR, Zeidner M. San Diego, CA, US: Academic; 2005:171–207.
71. Costa PT, McCrae RR: The NEO Five Factor Inventory (NEO FFI). Florida:
Psychological Assessment Resources Inc.; 1992.
72. Carver CS: Impulse and constraint: Perspectives from personality
psychology, convergence with theory in other areas, and potential for
integration. Person Soc Psychol Rev 2005, 9:312–333.
73. Roberts BW, Chernyshenko OS, Stark S, Goldberg LR: The structure of
conscientiousness: An empirical investigation based on seven major
personality questionnaires. Pers Psychol 2005, 58:103–139.
74. Baumeister RF, Gailliot M, DeWall CN, Oaten M: Self-regulation and
personality: How interventions increase regulatory success, and how
depletion moderates the effects of traits on behavior. J Personality 2006,
74:1773–1801.
75. Hoyle RH: Personality processes and problem behavior. J Pers 2000,
68:953–966.
76. Terracciano A, McCrae RR, Brant LJ, Costa PT Jr: Hierarchical linear
modeling analyses of NEO-PI-R scales in the Baltimore Longitudinal
Study of Aging. Psychol Aging 2005, 20:493–506.
77. Terracciano A, Costa PT Jr, McCrae RR: Personality plasticity after age 30.
Pers Soc Psychol Bull 2006, 32:999–1009.
78. Roberts BW, Mroczek D: Personality trait change in adulthood. Curr Dir
Psychol Sci 2008, 17:31–35.
79. Roberts BW, Walton KE, Viechtbauer W: Patterns of mean-level change in
personality traits across the life course: A meta-analysis of longitudinal
studies. Psychol Bull 2006, 132:1–25.
80. Costa PT Jr, Terracciano A, McCrae RR: Gender differences in personality
traits across cultures: robust and surprising findings. J Pers Soc Psychol
2001, 81:322–331.
81. Feingold A: Gender differences in personality: A meta-analysis. Psychol
Bull 1994, 116:429–456.
82. Kling KC, Hyde JS, Showers CJ, Buswell BN: Gender differences in self-
esteem: A meta-analysis. Psychol Bull 1999, 125:470–500.
83. McCrae RR, Terracciano A: Personality profiles of cultures: Aggregate
personality traits. J Pers Soc Psychol 2005, 89:407–425.
84. Allik J, McCrea RR: Toward a geography of personality traits: patterns of
profiles across 36 cultures. J Cross-Cultural Psychol 2004, 35:13–28.
85. Taras V, Kirkman BL, Steel P: Examining the impact of culture's
consequences: A three-decade, multilevel, meta-analytic review of
Hofstede's cultural value dimensions. J Appl Psychol 2010,
95:405–439.
86. Foldes HJ, Duehr EE, Ones DS: Group differences in personality: Meta-
analyses comparing five U.S. racial groups. Personnel Psychol 2008,
61:579–616.
87. Baron RM, Kenny DA: The moderator-mediator variable distinction in
social psychological research: Conceptual, strategic, and statistical
considerations. J Pers Soc Psychol 1986, 51:1173–1182.
88. Evans JS: Dual-processing accounts of reasoning, judgment, and social
cognition. Annu Rev Psychol 2008, 59:255–278.
89. Zelazo PD, Cunningham W: Executive function: Mechanisms underlying
emotion regulation. In Handbook of emotion regulation. Edited by Gross J.
New York: Guilford Press; 2007:135–158.
Jones et al. BMC Public Health 2012, 12:587 Page 15 of 17
http://www.biomedcentral.com/1471-2458/12/587
90. Sherman JW, Gawronski B, Gonsalkorale K, Hugenberg K, Allen TJ, Groom
CJ: The Self-regulation of automatic associations and behavioral
impulses. Psychol Rev 2008, 115:314–335.
91. Hughes S, Barnes-Holmes D, de Houwer J: The dominance of associative
theorizing in implicit attitude research: propositional and behavioural
alternatives. Psychol Record 2011, 61:465–496.
92. Nosek BA, Hawkins CB, Frazier RS: Implicit social cognition: from measures
to mechanisms. Trends Cogn Sci 2011, 15:152–159.
93. McClelland DC, Koestner R, Weinberger J: How do self-attributed and
implicit motives differ? Psychol Rev 1989, 96:690–702.
94. Greenwald AG, Banaji MR: Implicit social cognition: attitudes, self-esteem,
and stereotypes. Psychol Rev 1995, 102:4–27.
95. Greenwald AG, Banaji MR, Rudman LA, Farnham SD, Nosek BA, Mellott DS:
A unified theory of implicit attitudes, stereotypes, self-esteem and self-
concept. Psychol Rev 2002, 109:3–25.
96. Conner MT, Perugini M, O’Gorman R, Ayres K, Prestwitch A: Relations
between implicit and explicit measures of attitudes and measures of
behaviour: evidence of moderation by individual difference variables.
Pers Soc Psychol Bull 2007, 33:1727–1740.
97. Nosek BA, Riskind RG: Policy implications of implicit social cognition.
Social Issues Policy Rev 2012, 6:113–147.
98. Greenwald AG, McGhee DE, Schwartz JLK: Measuring individual
differences in implicit cognition: the implicit association test. J Pers Soc
Psychol 1998, 74:1464–1480.
99. Pronin E: How we see ourselves and how we see others. Science 2008,
320:1177–1180.
100. Gawronski B, Hofmann W, Wilbur C: Are “implicit” attitudes unconscious?
Consciousness and Cognition 2006, 15:485–499.
101. De Houwer J, Moors A: How to define and examine the implicitness of
implicit measures. In Implicit measures of attitudes: Procedures and
controversies. Edited by Wittenbrink B, Schwarz N. New York: Guilford Press;
2007:179–194.
102. McDaniel MJ, Beier ME, Perkins AW, Goggin S, Frankel B: An assessment of
the fakeability of self-report and implicit personality measures. J Res Pers
2009, 43:682–685.
103. Greenwald AG, Poehlman TA, Uhlmann EL, Banaji MR: Understanding and
using the Implicit Association Test: III. Meta-analysis of predictive
validity. J Pers Soc Psychol 2009, 97:17–41.
104. Perugini M, Richetin J, Zogmaister C: Prediction of behavior. In Handbook
of implicit social cognition: measurement, theory, and applications. Edited by
Gawronski B, Payne BK. New York: Guilford Press; 2010:255–277.
105. Maison D, Greenwald AG, Bruin R: Predictive validity of the Implicit
Association Test in studies of brands, consumer attitudes, and behavior.
J Consum Psychol 2004, 14:405–415.
106. Brunel FF, Tietje BC, Greenwald AG: Is the Implicit AssociationTest a valid
and valuable measure of implicit consumer social cognition? J Consum
Psychol 2004, 14:385–404.
107. Bargh JA: Losing consciousness: Automatic influences on consumer
judgment, behavior, and motivation. J Consum Res 2002, 29:280–285.
108. von Hippel W, Brener L, von Hippel C: Implicit prejudice toward injecting
drug users predicts intentions to change jobs among drug and alcohol
nurses. Psychol Sci 2008, 19:7–11.
109. Petróczi A, Uvacsek M, Deshmukh N, Shah I, Nepusz T, Aidman EV, Tóth M,
Barker J, Naughton DP: Incongruence in doping related attitudes, beliefs
and opinions in the context of discordant behavioural data: In which
measure do we trust? PLoS One 2011, 6:e18804.
110. Vianello M, Robusto E, Anselmi P: Implicit conscientiousness predicts
academic performance. Pers Indiv Diff 2010, 48:452–457.
111. Nock MK, Banaji MR: Prediction of suicide ideation and attempts among
adolescents using a brief performance-based test. J Consult Clin Psychol
2007, 75:707–715.
112. Nock MK, Park JM, Finn CT, Deliberto TL, Dour HJ, Banaji MR: Measuring the
suicidal mind: implicit cognition predicts suicidal behavior. Psychol Sci
2010, 21:511–517.
113. Stacy AW, Wiers RW: Implicit cognition and addiction: a tool for
explaining paradoxical behaviour. Ann Rev Clin Psychol 2010, 6:551–575.
114. Rothman AJ, Sheeran P, Wood W: Reflective and automatic processes in
the initiation and maintenance of dietary change. Ann Behav Med 2009,
38(Suppl 1):S4–17.
115. Millar MG: Predicting dental flossing behavior: the role of implicit and
explicit responses and beliefs. Basic Appl Soc Psychol 2011, 33:7–15.
116. Grenard JL, Ames SL, Stacy AW: Deliberative and spontaneous cognitive
processes associated with HIV risk behavior. J Behav Med 2012,
doi:10.1007/s10865-012-9404-6.
117. Sriram N, Greenwald AG: The Brief Implicit Association Test. Exp Psychol
2009, 56:283–294.
118. Hofmann W, Gawronski B, Gschwendner T, Le H, Schmitt M: A meta-
analysis on the correlation between the implicit association test and
explicit self-report measures. Pers Soc Psychol Bull 2005,
31:1369–1385.
119. Olson MA, Fazio RH: Implicit and explicit measures of attitudes: The
perspective of the MODE mode. In Attitudes: Insights from the new implicit
measures. Edited by Petty RE, Fazio RH, Briñol P. New York, NY: Psychology
Press; 2008:19–63.
120. Lucas GM: Antiretroviral adherence, drug resistance, viral fitness and HIV
disease progression: a tangled web is woven. J Antimicrob Chemother
2005, 55:413–416.
121. Bernard L, Peytavin G, Vuagnat A, de Truchis P, Perronne C: Indinavir
concentrations in hair from patients receiving highly active antiretroviral
therapy. Lancet 1998, 352:1757–1758.
122. Duval X, Peytavin G, Breton G, Ecobichon JL, Descamps D, Thabut G, Leport
C: Hair versus plasma concentrations as indicator of indinavir exposure
in HIV-1-infected patients treated with indinavir/ritonavir combination.
AIDS 2007, 21:106–108.
123. Huang Y, Yang Q, Yoon K, Lei Y, Shi R, Gee W, Lin ET, Greenblatt RM,
Gandhi M: Microanalysis of the antiretroviral nevirapine in human hair
from HIV-infected patients by liquid chromatography-tandem mass
spectrometry. Anal Bioanal Chem 2011, 401:1923–1933.
124. Huang Y, Gandhi M, Greenblatt RM, Gee W, Lin ET, Massenkoff N: Sensitive
analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human
hair by liquid chromatography coupled with tandem mass spectrometry.
Rapid Commun Mass Spectrom 2008, 22:3401–3409.
125. Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL,
Cohen M, Young M, Huang Y, Greenblatt RM, Women's Interagency HIV
Study (WIHS): Protease inhibitor levels in hair strongly predict virologic
response to treatment. AIDS 2009, 23:471–478.
126. Crosby RD, Kolotkin RL, Williams GR: Defining clinically meaningful change
in health-related quality of life. J Clin Epidemiol 2003, 56:395–407.
127. de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM:
Minimal changes in health status questionnaires: distinction between
minimally detectable change and minimally important change. Health
Qual Life Outcomes 2006, 4:54.
128. O'Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen
RC, Lucas JA: Detecting dementia with the mini-mental state
examination in highly educated individuals. Arch Neurol 2008, 65:963–967.
129. Peterman AH, Cella D, Mo F, McCain N: Psychometric validation of the
revised Functional Assessment of Human Immunodeficiency Virus
Infection (FAHI) quality of life instrument. Qual Life Res 1997,
6:572–584.
130. Haddock CK, Poston WSC, Pyle SA, Klesges RC, Vander Weg MW, Peterson A,
Debon A: The validity of self-rated health as a measure of health status
among young military personnel: evidence from a cross-sectional
survey. Health Qual Life Outcomes 2006, 4:57.
131. Epstein S, Pacini R, Denes-Raj V, Heier H: Individual differences in intuitive–
experiential and analytical–rational thinking styles. J Pers Social Psychol
1996, 71:390–405.
132. Strahan R, Gerbasi KC: Short, homogeneous versions of the Marlowe-
Crowne Social Desirability Scale. J Clin Psychol 1972, 28:191–193.
133. International Physical Activity Questionnaire (IPAQ); [https://sites.google.com/
site/theipaq/].
134. Sheeran P: Intention-behaviour relations: a conceptual and empirical
review. In European review of social psychology. 12th edition. Edited by
Stroebe W, Hewstone M. New York: Wiley; 2002:1–30.
135. NAISD Adult AIDS Clinical Trials Group: ACTG Baseline Adherence
Questionnaire; https://actgnetwork.org.
136. Greenwald AG, Nosek BA, Banaji MR: Understanding and using the implicit
association test: I. An improved scoring algorithm. J Pers Soc Psychol 2003,
85:197–216.
137. Nosek BA, Bar-Anan Y, Sriram N, Greenwald AG: Understanding and using the
Brief Implicit Association Test: I. Recommended scoring procedures.; 2012.
Unpublished manuscript posted on the Project Implicit website [http://
projectimplicit.net/papers.html] on 02/01/2012.
Jones et al. BMC Public Health 2012, 12:587 Page 16 of 17
http://www.biomedcentral.com/1471-2458/12/587
138. Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: A flexible statistical
power analysis program for the social, behavioral, and biomedical
sciences. Behav Res Methods 2007, 39:175–191.
139. NHS Code of Confidentiality; [http://www.dh.gov.uk/prod_consum_dh/
groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4069254.pdf].
140. Human Tissue Act; 2004 [http://www.legislation.gov.uk/ukpga/2004/30/
contents].
141. Health Protection Agency- HIV- diagnosed persons seen for HIV care survey of
prevalent HIV infections diagnosed (SOPHID) South East London data tables;
2010 [http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/
1222928474546].
142. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS: Adherence in
glaucoma: objective measurements of once-daily and adjunctive
medication use. Am J Ophthalmol 2007, 144:533–540.
143. Gray SL, Mahoney JE, Blough DK: Medication adherence in elderly
patients receiving home health services following hospital discharge.
Ann Pharmacother 2001, 35:539–45.
144. Winkler A, Teuscher AU, Mueller B, Diem P: Monotoring adherence to
prescribed medication in type 2 diabetic patients treated with
sulfonylureas. Swiss Med Wkly 2002, 132:379–385.
145. Skrajner MJ, Camp CJ, Heckman TG, Haberman JL, Kochman A: A fluctuating
pattern of over- and under-adherence for HAART: A case study from a
Videophone Intervention Project. Clin Gerontol 2011, 34:144–153.
doi:10.1186/1471-2458-12-587
Cite this article as: Jones et al.: Understanding how adherence goals
promote adherence behaviours: a repeated measure observational
study with HIV seropositive patients. BMC Public Health 2012 12:587.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Jones et al. BMC Public Health 2012, 12:587 Page 17 of 17
http://www.biomedcentral.com/1471-2458/12/587
